Loading clinical trials...
Loading clinical trials...
The project will use carbon-13 magnetic resonance spectroscopy to assess whether high glycogen levels in skeletal muscle of patients with Glycogen Storage Diseases is a prelude for muscle damage. Pat...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Rigshospitalet, Denmark
Collaborators
NCT06666413 · Glycogen Storage Disease Type II, Pompe's Disease
NCT06843330 · Glycogen Storage Disease Type Ia
NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more
NCT06616545 · Glycogen Storage Disease Type III
NCT06396546 · Glycogen Storage Diseases
Neuromuscular Research Unit, 8077
Copenhagen, Copenhange
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions